Contact
Please use this form to send email to PR contact of this press release:
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages TG Therapeutics (TGTX) Investors with Losses to Contact Firm's Attorneys Before Sept. 16th Application Deadline in Securities Fraud Class Action
TO: